Innovations in exosome isolation techniques, such as
ultracentrifugation, immunoaffinity capture, and microfluidics, are
enhancing the efficiency, yield, and purity of exosome isolation,
making the process more viable for clinical applications.
WILMINGTON, Del., July 15, 2024 /PRNewswire/ -- The exoscome
isolation market was projected to attain US$
370.7 million in 2023. It is likely to garner an 11.6% CAGR
from 2024 to 2034, and by 2034, the market is expected to attain
US$ 1.2 billion. The trend
towards personalized medicine, which involves tailoring treatment
based on individual patient characteristics, is driving the demand
for exosome-based diagnostics and therapeutics due to their
potential in providing personalized treatment options.
Progress in technologies like next-generation sequencing (NGS),
proteomics, and advanced microscopy is facilitating better
characterization and understanding of exosomes, propelling their
use in various applications. Exosomes are increasingly being
integrated with liquid biopsy techniques for non-invasive cancer
diagnostics and monitoring. This trend is expected to significantly
drive market growth due to the rising adoption of liquid
biopsies.
The development and clinical trials of exosome-based
therapeutics are gaining momentum. These therapeutics are being
explored for a range of applications, including targeted drug
delivery and regenerative medicine. The introduction of automated
and high-throughput exosome isolation systems is streamlining the
isolation process, reducing manual labor, and increasing
reproducibility, which is likely to boost market adoption.
Download Sample PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86186
The unique properties of exosomes, such as their natural origin
and ability to cross biological barriers, are being leveraged in
drug delivery systems. This is an area with substantial growth
potential as more pharmaceutical companies explore exosome-based
delivery platforms. The integration of AI and machine learning
technologies in exosome research can enhance data analysis,
biomarker discovery, and personalized treatment strategies, driving
innovation and market growth.
Key Findings of Market Report
- Governments across the globe are increasingly supporting
research in the field of exosomes through funding, grants, and
policy frameworks. This governmental backing is crucial for
advancing exosome research and development.
- There is a growing preference for non-invasive diagnostic
methods among patients and healthcare providers. Exosomes,
which can be isolated from bodily fluids like blood and urine,
provide a promising avenue for non-invasive diagnostics.
- Growing awareness about the potential of
exosome-based applications among healthcare professionals and
researchers is driving market demand. Educational initiatives and
conferences are playing a key role in disseminating knowledge.
- An increasing number of clinical trials focusing on
exosome-based diagnostics and therapeutics are being
conducted, showcasing their potential and driving market interest
and investment.
Exosome Isolation Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 370.7 Mn
|
Forecast (Value) in
2034
|
US$ 1.2 Bn
|
Growth Rate
(CAGR)
|
11.6 %
|
No. of
Pages
|
126
Pages
|
Segments
covered
|
By Technique, By
Application, By Region, By End-user
|
Market Trends for Exosome Isolation
- By technique, the ultracentrifugation segment is expected
to boost the growth of the exosome isolation market.
- Ultracentrifugation is renowned for its ability to provide
high-purity exosome samples, which is crucial for downstream
applications in diagnostics and therapeutics. This technique
efficiently separates exosomes from other
extracellular vesicles and contaminants, making it a preferred
choice for researchers.
- On the basis of application, the diagnostic applications
segment is anticipated to boost the growth of the
exosome isolation market.
Global Market for Exosome Isolation: Regional Outlook
North America
- The region is at the forefront of technological advancements
in exosome isolation and analysis. Innovations such as
improved ultracentrifugation techniques, microfluidics, and
next-generation sequencing are enhancing the efficiency and
effectiveness of exosome-based research and applications.
- The trend towards precision and personalized medicine is strong
in North America. Exosome-based diagnostics and
therapeutics align well with this approach, providing tailored
solutions based on individual patient profiles.
Asia Pacific
- The trend towards personalized medicine is gaining momentum in
the Asia Pacific
region. Exosome-based diagnostics and therapeutics align well
with the personalized medicine approach, providing tailored
solutions based on individual patient profiles.
- The robust economic growth in many Asia Pacific countries is creating favorable
conditions for investment in biotechnology and healthcare. Venture
capital, government grants, and other funding sources are
supporting the growth of the exosome isolation
market.
Request Table of Content
Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=86186
Exosome Isolation Market: Key Players
The exosome isolation market is highly competitive and
characterized by the presence of several key players, ranging from
established biotechnology and pharmaceutical companies to
specialized startups and research institutions.
The competition is driven by innovations in isolation
techniques, product offerings, strategic partnerships, and
extensive research and development activities. The following
companies are well known participants in the exosome isolation
market:
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Miltenyi Biotec
- Sistema-Bio
- Norgen Biotek
- System Biosciences, LLC
- STEMCELL Technologies Canada Inc.
- Sigma-Aldrich
- Lonza Group
- Bio-Techne (Exosome Platform - Diagnostics)
Key Developments
- In July 2022, Cells for Cells
announced a six-month follow-up on exceptional clinical data from
the first patient treated with their exosome-based therapy for
osteoarthritis.
- In the same year, Global Stem Cells Group (GSCG) announced the
launch of its new product featuring lyophilized
exosome technology.
Exosome Isolation Market Segmentation
Technique
- Ultracentrifugation
- Size-exclusion Chromatography
- Polymer-based Precipitation
- Immunoaffinity Capture
- Microfluids
- Exosome Precipitation Kits
- Others
Application
- Research Applications
- Diagnostic Applications
- Therapeutic Applications
- Others
End User
- Academic and Research Institutions
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Others
Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Purchase the Report for Market-Driven Insights:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86186<ype=S
Have a Look at More Valuable Insights of Healthcare
- Smoke Evacuation Systems Market: The global
market for smoke evacuation systems was projected to have a market
value worth US$ 158.5 million
in 2021. The market is anticipated to advance with a 6.6%
CAGR from 2022 to 2031 and by 2031; the market is likely to
reach US$ 298.8 million.
- Cell Therapy Market: The market for cell therapy
was valued at US$ 10
million in 2022. The CAGR between 2022 and
2032 is expected to reach 18.7%. By 2032, the market is
expected to reach US$ 54.6
million. Several rare and genetic diseases are being
treated with cell therapies. Researchers will continue to
investigate these conditions, and clinical trials will develop,
which may increase demand for cell therapies.
- Rapid Microbiology Testing Market: The
Rapid Microbiology Testing Market, valued at US$ 4.1 billion in 2023, is projected to grow
at a CAGR of 5.7% from 2024 to 2034, reaching more than
US$ 7.6 billion by the end of
2034.
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington,
Delaware, United States,
provides custom research and consulting services. Our exclusive
blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use
proprietary data sources and various tools & techniques to
gather and analyses information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington,
Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
Logo -
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/exosome-isolation-market-set-for-robust-growth-to-us-1-2-billion-through-2034-ai-integration-offers-promising-opportunities-reports-transparency-market-research-302197030.html